Andrew R. Jones, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2051 Hamill Rd, Suite 400, Hixson, TN 37343 Phone: 423-877-4549 Fax: 423-875-8510 |
Susan M Shuck, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2051 Hamill Rd, Suite 211, Hixson, TN 37343 Phone: 423-702-9240 |
Dr. Christopher Ian Innes, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2051 Hamill Rd, Suite 211, Hixson, TN 37343 Phone: 423-702-9240 |
Dr. James E Abell, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2051 Hamill Rd, Suite 301, Hixson, TN 37343 Phone: 423-778-9500 Fax: 423-778-9525 |
Dr. Elizabeth Erin Scarbrough, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2051 Hamill Rd Ste 400, Hixson, TN 37343 Phone: 423-877-4549 |
News Archive
The effects of using face paints for Halloween can be scary, says Sofia Chaudhry, M.D., assistant professor of dermatology at Saint Louis University.
British scientists have come up with a novel idea. They suggested that junk food counters should hand out free cholesterol-lowering statin drugs to their customers to "neutralize" the heart risks of eating fatty foods like burgers and fries. The idea is to project having high cholesterol fatty food as risky a behavior as driving or smoking that needs the user to go for seatbelts and filtered cigarettes respectively.
Scientists at the University of Wisconsin Carbone Cancer Center (UWCCC) report that a new class of tumor-targeting agents can seek out and find dozens of solid tumors, even illuminating brain cancer stem cells that resist current treatments.
Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced the U.S. Food and Drug Administration (FDA) has agreed to the Company's updated product specifications for SURFAXIN® (lucinactant) Intratracheal Suspension which was approved for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.
GeckoSystems Intl. Corp. today announced that Martin Spencer, GeckoSystems' president and chief executive officer, will discuss the role of robots in the future of healthcare during their "Mobile Robots in Motion" conference in Atlanta, Ga. GeckoSystems is a dynamic leader in the emerging mobile robotics industry, revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service™."
› Verified 8 days ago